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Abstract
Tumor samples are heterogeneous. They consist of different subclones that are charac-
terized by differences in DNA nucleotide sequences and copy numbers on multiple loci.
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Heterogeneity can be measured through the identification of the subclonal copy number
and sequence at a selected set of loci. Understanding that the accurate identification of
variant allele fractions greatly depends on a precise determination of copy numbers, we
develop a Bayesian feature allocation model for jointly calling subclonal copy numbers
and the corresponding allele sequences for the same loci. The proposed method utilizes
three random matrices, L, Z and w to represent subclonal copy numbers (L), num-
bers of subclonal variant alleles (Z) and cellular fractions of subclones in samples (w),
respectively. The unknown number of subclones implies a random number of columns
for these matrices. We use next-generation sequencing data to estimate the subclonal
structures through inference on these three matrices. Using simulation studies and
a real data analysis, we demonstrate how posterior inference on the subclonal struc-
ture is enhanced with the joint modeling of both structure and sequencing variants on
subclonal genomes. Software is available at http://compgenome.org/BayClone2.
Keywords: Categorical Indian buffet process; Feature allocation models; Markov
chain Monte Carlo; Next-generation sequencing; Random matrices; Subclone; Variant
Calling.
1 Introduction
1.1 Biological background and motivation
Understanding tumor heterogeneity (TH) is critical for precise cancer prognosis. Not all
tumor cells have the same genome and respond to the same treatment. TH arises when
somatic mutations occur in only a fraction of tumor cells, and results in the observed spatial
and temporal heterogeneity of tumor samples (Russnes et al., 2011; Greaves and Maley, 2012;
Frank and Nowak, 2004; Biesecker and Spinner, 2013; Frank and Nowak, 2003; De, 2011;
Bedard et al., 2013; Navin et al., 2011; Ding et al., 2012). In other words, a tumor sample
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is composed of different subclones of cells with each subclone being defined by a unique
genome. Figure 1(a) illustrates this process with a hypothetical case in which accumulation
of variants over the lifetime of a tumor gives rise to different subpopulations of tumor cells.
Researchers have recently started to recognize the importance of TH and realize the mistake
of treating cancer using a one-size-fits-all approach. Instead, precision medicine now aims to
focus on targeted treatment of individual tumors based on their molecular characteristics,
including TH.
Rapid progress has been made in the development of computational tools for clonal
inference in the past year (Oesper et al., 2013; Miller et al., 2014; Strino et al., 2013; Jiao
et al., 2014; Zare et al., 2014). New methods continue to set new and higher standards
in the statistical inference for TH that mimic the underlying biology ever more closely.
However, the current literature still lacks effective methods, computational or experimental,
for assessing differences between subclonal genomes in terms of both structure variants, such
as copy number variants (CNVs), and in terms of sequence variants, such as single nucleotide
variants (SNVs). More importantly, current methods lack computational models that could
jointly estimate copy numbers and variant allele counts within each subclone. Recent work
by Li and Li (2014) adjusts the estimation of subclonal cellular fractions for both CNVs
and SNVs, but still stops short of directly inferring subclonal copy numbers or variant allele
counts.
Figure 1(b) shows a stylized example of DNA-Seq data for a sample taken on day 360 of
the process shown in Figure 1(a). The sample is a result of the underlying tumor evolution.
The sample has three tumor subclones. If the sample is sequenced and short reads are
mapped, the total number of reads mapped to each locus will be affected by the copy
numbers of all the subclones. In Figure 1(b), due to the copy number gains in subclones
2 and 3, we expect that there will be additional reads with sequence A at locus 1 and
additional reads with sequence G at locus 3 (both marked by brown letters). In addition,
3
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Figure 1: (a) Tumor heterogeneity caused by clonal expansion.
On days 90, 180, and 360, four somatic mutations (represented
by red letters) and three somatic copy number gains (represented
by brown letters) result in three tumor subclones. (b) Observed
short reads (some with variants) are results of heterogeneous
subclonal genomes. In particular, the formula at the bottom
shows that subclonal alleles are mixed in proportions to produce
short reads, which are mapped to different loci.
Subclone 1 Subclone 2 Subclone 3 Normal Clone
locus 1 2 3 2 2
locus 2 2 2 2 2
locus 3 2 2 4 2
L
Subclone 1 Subclone 2 Subclone 3 Normal Clone
locus 1 0 1 1 0
locus 2 1 0 1 0
locus 3 0 0 0 0
Z
Subclone 1 Subclone 2 Subclone 3 Normal Clone
Day 90 30% 0 0 70%
Day 180 30% 15% 0 55%
Day 360 20% 15% 10% 55%
W
Figure 2: Three matrices for infer-
ence to describe the subclonal struc-
ture in Figure 1. L describes the sub-
clonal copy numbers, Z describes the
numbers of subclonal variant alleles,
and w describes the cellular fractions
of subclones.
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variant short reads will be generated due to the subclonal mutations in the sample, such
as short reads with the red letters mapped to loci 1 and 2. Using NGS data we aim to
recover the subclonal sequences at these loci and cellular fractions at the bottom of Figure
1(b) that explains the true biology in (a). In particular, we aim to provide three matrices
as shown in Figure 2 to describe the subclonal genomes and sample heterogeneity. For
illustration, Figure 2 fills in the (biological) truth for these three matrices corresponding to
the hypothetical tumor heterogeneity described in Figure 1(a). In an actual data analysis,
all three matrices are latent and must be estimated.
1.2 Model-based Inference for Tumor Heterogeneity
We propose a new class of Bayesian feature allocation models (Broderick et al., 2013) to
implement inference on these three matrices. We first construct an integer-valued matrix L
to characterize subclonal copy numbers. Each column corresponds to a subclone and rows
correspond to loci. We use the column vector `c = (`1c, . . . , `Sc) of integers to represent copy
numbers across S loci for subclone c. For example, in Figure 2, `sc = 3 for s = 1 and c = 2
since subclone 2 has three alleles at locus 1. As a prior distribution for L, p(L), we will
define a finite version of a categorical Indian buffet process (Sengupta, 2013; Sengupta et al.,
2015), a new feature allocation model.
Next, we introduce a second integer-valued matrix Z with the same dimensions as L.
We use Z to record SNV’s. Denote by zc the c-th column of Z. Conditional on `c, zc =
(z1c, . . . , zSc), zsc ≤ `sc, represents the number of alleles that bear a mutant sequence different
from the reference sequence at locus s, s = 1, . . . , S in subclone c. For example, in Figure 2,
zsc = 1 for s = 2 and c = 1, indicating that one allele bears a variant sequence. By definition,
the number of variant alleles zsc in a subclone cannot be larger than the copy number `sc
of the subclone, i.e., zsc ≤ `sc. Jointly, the two random integer vectors, `c and zc describe a
subclone and its genetic architecture at the corresponding loci. Lastly, we introduce the w
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matrix. Each row wt = (wt1, . . . , wtC) represents the cellular fractions of the C subclones in
each sample (and we will still add an additional subclone c = 0).
The remainder of the paper is organized as follows: Section 2 describes the proposed
Bayesian feature allocation model. Section 3 describes simulation studies. Section 4 reports
a data analysis for an in-house data set to illustrate intra-tumor heterogeneity. The last
section concludes with a final discussion.
2 Probability Model
2.1 Sampling model
Suppose that T samples have been sequenced in an NGS experiment. These samples are
assumed to be from the same patient, obtained either at different time points or different
geographical locations within the tumor. Suppose that we have collected read mapping data
on S loci for the T samples using bioinformatics pipelines such as e.g., BWA (Li and Durbin,
2009a), Samtools (Li et al., 2009), GATK (McKenna et al., 2010b), etc. Let N and n
denote S × T matrices of these counts, Nst and nst denoting the total number of reads and
the number of reads that bear a mutated sequence, respectively, at locus s for tissue sample
t, s = 1, . . . , S and t = 1, . . . , T . Following Klambauer et al. (2012), we assume a Poisson
sampling model for Nst,
Nst | φt,Mst indep∼ Poi(φtMst/2). (1)
Here, Mst is the sample copy number that represents an average copy number across sub-
clones. We will formally define and model Mst using subclonal copy numbers (L) next. φt
is the expected number of reads in sample t if there were no CNV (the sample copy number
equals 2). That is, when Mst = 2, the Poisson mean becomes φt.
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Conditional on Nst we assume a binomial sampling model for nst conditional on Nst;
nst | Nst, pst indep∼ Bin(Nst, pst). (2)
Here pst is the success probability of observing a read with a variant sequence. It is interpreted
as the expected variant allele fractions (VAFs) in the sample. In the following discussion we
will represent pst in terms of the underlying matrices L and Z.
2.2 Prior
Construction of Mst. Let C denote the unknown number of subclones in T samples. We
first relate Mst to CNV at locus s for sample t. We construct a prior model for Mst in two
steps, using the notion that each sample is composed of a mixture of C subclones. Let wtc
denote the proportion of subclone c, c = 1, . . . , C, in sample t and let `sc ∈ {0, 1, 2, . . . , Q}
denote the number of copies at locus s in subclone c where Q is a pre-specified maximum
number of copies. Here Q is an arbitrary upper bound that is used as a mathematical device
rather than having any biological meaning. The event `sc = 2 means no copy number variant
at locus s in subclone c, `sc = 1 indicates one copy loss and `sc = 3 indicates one copy gain.
Then the mean number of copies for sample t can be expressed as the weighted sum of the
number of copies over C latent subclones where the weight wtc denotes the cellular fractions
of subclone c in sample t. We assume
Mst = `s0wt0 +
C∑
c=1
wtc`sc, (3)
The second term
∑C
c=1wtc`sc reflects the key assumption of decomposing the sample copy
number into a weighted average of subclonal copy numbers. The first term, `s0wt0 denotes
the expected copy number from a background subclone to account for potential noise and
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artifacts in the data, labeled as subclone c = 0. We assume no CNVs at any the locations
for the background subclone, that is, `s0 = 2 for all s.
Prior on L. We develop a feature-allocation prior for a latent random matrix of copy
numbers, L = [`sc], c = 1, . . . , C and s = 1, . . . , S. We first construct a prior p(L | C)
conditional on C. Let pic = (pic0, pic1, . . . , picQ) where p(`sc = q) = picq and
∑Q
q=0 picq = 1.
As a prior distribution of pic, we use a beta-Dirichlet distribution developed in Kim et al.
(2012). Conditional on C, p(`sc 6= 2) = (1−pic2) follows a beta distribution with parameters,
α/C and β and p˜i = (pic0, pic1, pic3, . . . , picQ), where picq = picq/(1 − pic2) with q 6= 2, follows a
Dirichlet distribution with parameters, (γ0, γ1, γ3, . . . , γQ). Assuming a priori independence
among subclones, we write pic
iid∼ Be-Dir(α/C, β, γ0, γ1, γ3, . . . , γQ). For β = 1, the marginal
limiting distribution of L can be shown to define a categorical Indian buffet process (cIBP)
as C →∞ (Sengupta, 2013; Sengupta et al., 2015).
Construction of pst and prior on Z. To model the expected VAF of the sample, pst,
we construct another feature allocation model linking pst with `sc. We introduce an S × C
matrix, Z whose entries, zsc ∈ {0, . . . , `sc} denote the number zsc ≤ `sc of alleles bearing a
variant sequence among the total of `sc copies at locus s in subclone c. Assume zsc = 0 if
`sc = 0, and given `sc > 0,
zsc | `sc ∼ DU(0, 1, . . . , `sc), (4)
where DU(·) indicates a discrete uniform distribution.
Next, we write pst in (2) as a ratio between the expected number of variant alleles and
the expected sample copy number. In particular, the expected number of variant alleles is a
weighted sum of subclonal variant allele counts over (C + 1) latent subclones including the
background subclone, and the expected VAF is
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pst =
p0zs0wt0 +
∑C
c=1wtczsc
Mst
(5)
Similar to the previous argument for (3), the term
∑C
c=1wtczsc in (5) reflects the assumption
that the sample-level variant allele count is a weighted average of subclonal variant allele
counts. The first term of the numerator, p0zs0wt0 describes the background subclone and
experimental noise. Specifically, we let zs0 = 2 for all s to denote the number of variant
alleles in the background subclone. We add a global parameter p0 to account for artifacts
and experimental noise that would produce variant reads even if no subclones were to possess
variant alleles. Since p0 does not depend on s or t, it can be estimated by pooling data
from all loci and samples, and does not affect the identifiability of the model. We consider
p0 ∼ Be(a00, b00) with a00  b00 to inform a small p0 value a priori. Equation (5) echos our
previous discussion for Figure 1(b), modeling the VAFs as a mixture of subclonal variant
alleles.
Prior for w. Next, we introduce a prior distribution for the weights wtc in (3) and (5). The
subclones are common for all tumor samples, but the relative weights wtc vary across tumor
samples. We assume independent Dirichlet priors as follows. Let θtc denote an (unscaled)
abundance level of subclone c in tissue sample t. We assume θtc | C iid∼ Gamma(d, 1) for
c = 1, . . . , C and θt0
iid∼ Gamma(d0, 1). We then define
wtc = θtc/
C∑
c′=0
θtc′ ,
as the relative weight of subclone c in sample t. This is equivalent towt | C iid∼ Dir(d0, d, . . . , d)
for t = 1, . . . , T . Using d0 < d implies that the background subclone takes a smaller propor-
tion in a sample.
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Finally, we complete the model construction with a prior on the unknown number of
latent subclones C. We use a geometric distribution, C ∼ Geom(r) where E(C) = 1/r.
Conditional on C, the two latent matrices, L and Z describes C latent tumor subclones that
are thought of composing the observed samples and wt provides the relative proportions
over those C subclones in sample t. Joint inference on C, L, Z and wt explains tumor
heterogeneity.
The construction of the subclones, including the number of subclones, C, the subclonal
copy number, `sc, and the number of copies having SNV, zsc are latent. The subclones are
not directly observed. They are only defined as the components of the assumed mixture
that gives rise to the observed CNV and VAFs. The key terms,
∑C
c=1wtc`sc in (3) and∑C
c=1wtcztc/Mst in (5) allow us to indirectly infer subclones by explaining Mst and pst as
arising from sample t being composed of a mix of hypothetical subclones which have `sc
copies of which zsc actually carry a variant at locus s.
Lastly, we take account of different average read counts in T samples through φt. φt repre-
sents the expected read count with two copies in sample t and assume φt
indep∼ Gamma(at, bt)
where E(φt) = at/bt.
2.3 Posterior Simulation
Let x = (L,Z,θ,φ,pi, p0) denote all unknown parameters, where θ = {θtc} and pi = {picq}.
We implement inference via posterior Markov chain Monte Carlo (MCMC) simulation. That
is, by generating a Monte Carlo sample of xi ∼ p(x | n,N ), i = 1, . . . , I. MCMC posterior
simulation proceeds by sequentially using transition probabilities that update a subset of
parameters at a time. See, for example Brooks et al. (2011) for a review.
For fixed C such MCMC simulation is straightforward. Gibbs sampling transition proba-
bilities are used to update `sc, zsc, picq and φt and Metropolis-Hastings transition probabilities
are used to update θ and p0. It is possible to improve the mixing of the Markov chain by
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updating all columns in row s of the matrices L and Z jointly by means of a Metropolis-
Hastings transition probability that proposes changes in the entire row vector zs and `s.
The construction of transition probabilities that involves a change of C is more difficult,
since the dimension of L, Z, pi and θ changes as C varies. We use the approach proposed
in Lee et al. (2014) for posterior simulation in a similar model. We split the data into a
small training set (n′,N ′) with n′st = bstnst, N
′
st = bstNst, and a test data set, (n
′′
,N
′′
)
with n
′′
st = (1 − bst)nst etc. In the implementation we use bst generated from Be(25, 975)
for the simulation studies and Be(30, 970) for the lung cancer data. We found that using
a random bst worked better than a fixed fraction b across all samples and loci. Let p1(x |
C) = p(x | N ′,n′, C) denote the posterior distribution under C using the training sample.
We use p1 in two instances. First, we replace the original prior p(x | C) by p1(x | C)
and, second, we use p1(·) as proposal distribution q(x˜ | C˜) = p1(x˜ | C˜) in a reversible
jump (RJ) style transition probability where C˜ is a proposed value of C. The test data is
then used to evaluate the acceptance probability. The critical advantage of using the same
p1(·) as prior and proposal distribution is that the normalization constant cancels out in the
Metropolis-Hastings acceptance probability.
We summarize the joint posterior distribution, p(C,L,Z,pi,φ,w, p0 | n,N ) by factoriz-
ing it as
p(C | n,N ) p(L | n,N , C) p(Z,pi | n,N , C,L) p(w | L,Z,n, C) p(φ, p0 | n,N , C).
Using the posterior Monte Carlo sample we (approximately) evaluate the marginal posterior
p(C | n,N ) and determine the maximum a posteriori (MAP) estimate C?. We follow Lee
et al. (2014) to define L? conditional on C?. For any two S × C? matrices, L and L′,
1 ≤ c, c′ ≤ C?, let Dcc′(L,L′) =
∑S
s=1 |`sc − `′sc′|. We then define a distance d(L,L′) =
minσ
∑C?
c=1Dc,σc(L,L′), where σ = (σ1, . . . , σC) is a permutation of {1, . . . , C?} and the
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minimum is over all possible permutations. A posterior point estimate for L is defined as
L? = arg min
L′
∫
d(L,L′) dp(L | n,N , C?) ≈ arg min
L′
I∑
i=1
d(L(i),L′),
for a posterior Monte Carlo sample, {L(i), i = 1, . . . , I}. We report posterior point estimates
Z?, w? and pi? conditional on C? and L?. Finally, we report φ? and p?0 as the posterior
mean of φ and p0 conditional on C
?.
3 Simulation
3.1 Simulation 1
We assess the proposed model via simulation. We generate hypothetical read counts for a
set of S = 100 loci in T = 4 hypothetical samples. In the simulation truth, we assume two
latent subclones (CTRUE = 2) as well as a background subclone (c = 0) with all SNVs bearing
variant sequences with two copies. We use Q = 3. The simulation truth LTRUE is shown in
Figure 3(a) where green color (light grey) in the panels indicates a copy gain (`sc = 3) and
red color (dark grey) indicates two copy loss (`sc = 0). Panel (b) shows the simulation truth
ZTRUE. Similar to LTRUE, green color indicates three copies with SNV and red color indicates
zero copies with SNV. We generate φTRUEt
iid∼ Gamma(600, 3), t = 1, . . . , 4 and then generate
wTRUE
iid∼ Dir(0.4, 30.0, 10.0). The weights wTRUE are shown in Figure 3(c). Similar to the
other heatmaps, green color (light grey) in panel (c) represents high abundance of a subclone
in a sample and red color (dark grey) shows low abundance. On average, subclone 1 takes wtc
close to 0.75 for all the samples, with little heterogeneity across samples. Using the assumed
LTRUE, ZTRUE and wTRUE and letting pTRUE0 = 0.05, we generate Nst ∼ Poi(φTRUEt MTRUEst /2)
and nst ∼ Bin(Nst, pTRUEst ).
To fit the proposed model, we fix the hyperparameters as r = 0.2, α = 2, γq = 0.5 for
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Figure 3: Simulation 1: simulation truth.
q = 0, 1, 3(= Q), d0 = 0.5, d = 1, a00 = 0.3 and b00 = 5. For the prior on φt, we let b = 3 and
specify a by setting the median of the observed Nst to be the prior mean. For each value of
C, we initialized Z using the observed sample proportions and L using the initial Z. We
generated initial values for θtc and p0 by prior draws. We generated bst
iid∼ Be(25, 975) to
construct the training set and ran the MCMC simulation over 16,000 iterations, discarding
the first 6,000 iterations as initial burn-in.
Figure 4(a) shows p(C | n,N ). The dashed vertical line marks the simulation truth
CTRUE = 2. The posterior mode C? = 2 recovers the truth. Panels (d) through (f) show the
posterior point estimates, L?, Z? and w?. Compared to the simulation truth in Figure 3,
the posterior estimate recovers subclone 1 with high accuracy, but `?c for subclone c = 2
shows some discrepancies with the simulation truth. This is due to small wTRUEtc , c = 2,
across all four samples (last column in Figure 3c). The discrepancy between `?2 and `
TRUE
2
is related to the misspecification of z?c under c = 2. Conditional on C
?, we computed Mˆst
and pˆst and compared to the true values. Figure 4(b) and (c) show a good fit under the
model for a majority of loci and samples although the histograms include a small pocket of
differences between the true values and their estimates on the right tail, also possibly due
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Figure 4: Posterior inference for Simulation 1.
to the misspecification of `2 and z2. This simulation study illustrates that the proposed
model reasonably recovers the simulation truth even with a small number of samples when
the underlying structure is not complex.
For comparison, we implemented PyClone (Roth et al., 2014) with the same simulated
data. We let the normal copy number, the minor parental copy number and the major
parental copy number be 2, 0 and 3, respectively, at each locus. PyClone considers copy
number changes and estimates the variant allelic prevalence (fraction of clonal population
having a mutation) at a locus in a sample. The interpretation of variant allelic prevalences,
referred to as “cellular prevalences” in PyClone, is similar to that of pst in the proposed
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Figure 5: Heatmaps of estimated cellular prevalences from PyClone (a) and pTRUEst (b) for
Simulation 1.
model. PyClone uses a Dirichlet process model to identify a (non-overlapping) clustering of
the loci based on their cellular prevalences. Cellular prevalences over loci and samples may
vary but the clustering of loci is shared by samples. Figure 5(a) shows posterior estimates of
the cellular prevalences (by color and grey shade) and mutational clustering (by separations
with white horizontal lines) under PyClone. Panel (b) of the figure shows a heatmap of pTRUEst .
The loci (rows) of the two heatmaps are re-arranged in the same order for easy comparison.
By comparing the two heatmaps, the cellular prevalence estimates under PyClone are close
to pTRUEst and lead to a reasonable estimate of a clustering of the loci. However, PyClone does
not attempt to construct a description of subclones with genomic variants.
3.2 Simulation 2
We carried out a second simulation study with a more complicated subclonal structure. We
simulate read counts for a set of S = 100 loci in T = 25 hypothetical samples. In the
simulation truth, we assume four latent subclones (CTRUE = 4) as well as a background
subclone (c = 0) with all SNVs bearing variant sequences with two copies. We use Q = 3.
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The simulation truths, LTRUE and ZTRUE are shown in Figure 6(a) and (b), respectively.
We generated φTRUEt from Gamma(600, 3) for t = 1, . . . , 25 and then generated w
TRUE
t as
follows. We let aTRUE = (13, 4, 2, 1) and for each t randomly permuted aTRUE. Let aTRUEpi
denote a random permutation of aTRUE. We generate wTRUE ∼ Dir(0.3,aTRUEpi ). That is,
the first parameter of the Dirichlet prior for the (CTRUE + 1)-dimensional weight vector was
0.3, and the remaining parameters were a permutation of aTRUE. The weights wTRUE are
shown in Figure 6(c). The samples in the rows are rearranged for better display. From
Figure 6(c), each sample has all the four subclones with its own cellular fractions, resulting
in large heterogeneity within a sample. In addition, the random permutation of aTRUE induces
heterogeneity among the samples. We observe that when the underlying subclonal structure
is complicate and samples are heterogeneous, larger sample size is needed. In particular,
T = 25 which is a large number compared to the typical sample size in real datasets is
assumed for this simulation study. Using the assumed LTRUE, ZTRUE and wTRUE and letting
pTRUE0 = 0.05, we generate Nst ∼ Poi(φTRUEt MTRUEst /2) and nst ∼ Bin(Nst, pTRUEst ). We fit the
proposed model as in the first simulation study.
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Figure 6: Simulation 2: simulation truth.
Figure 7(a) reports p(C | n,N ), again marking CTRUE with a dashed vertical line. The
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posterior mode C? = 4 correctly recovers the truth. Panels (d) through (f) summarize
the posterior point estimates, L?, Z? and w?. Posterior estimates accurately recover the
simulation truth for subclones 1 and 2, for which the true proportions wTRUEtc are large for
many samples, as shown in Figure 6(c). On the other hand, the posterior estimate for
subclones 3 and 4 shows discrepancies with the simulation truth. In particular, we observe
that a group of loci that have `TRUEsc = 1 in subclones 3 and 4 has `
?
sc = 2 for subclone 3 and
`?sc = 0 for subclone 4. We suspect that this reflects the small weights w
TRUE
tc for c = 3, 4 for
almost all samples, as seen in the last two columns of Figure 6(c). Notice also the bias in
the corresponding estimates, z?sc and w
?
tc, c = 3, 4. Despite ambiguity about the true latent
structure, we find a good fit to the data. Conditional on C?, we computed Mˆst and pˆst and
compared to the true values. Figure 7(b) and (c) show the summaries that indicate a good
fit.
For comparison, we again applied PyClone (Roth et al., 2014) to the same simulated
data. We used a similar setting for PyClone as in the previous simulation. Figure 8(a)
shows the estimated cellular prevalences. The reported clustering of loci (shown with by
separations with white horizontal lines) is reasonable. Compare with the simulation truth
pTRUEst in panel (b). The loci (rows) of the two heatmaps are re-arranged in the same order
for easy comparison. Again, PyClone does not attempt to reconstruct how subclones could
explain the observed data and does not provide inference on the true subclonal structure in
Figure 6.
4 Lung Cancer Data
We record whole-exome sequencing for four surgically dissected tumor samples taken from the
same patient with lung cancer. We extracted genomic DNA from each tissue and constructed
an exome library from these DNA using Agilent SureSelect capture probes. The exome
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Figure 7: Posterior inference for Simulation 2.
library was then sequenced in paired-end fashion on an Illumina HiSeq 2000 platform. About
60 million reads - each 100 bases long - were obtained. Since the SureSelect exome was about
50 Mega bases, raw (pre-mapping) coverage was about 120 fold. We then mapped the reads
to the human genome (version HG19) (Church et al., 2011) using BWA (Li and Durbin,
2009b) and called variants using GATK (McKenna et al., 2010a). Post-mapping, the mean
coverage of the samples was between 60 and 70 fold.
A total of nearly 115,000 SNVs and small indels were called within the exome coordinates.
We restricted our attention to SNVs that (i) make a difference to the protein translated from
the gene, and (ii) that exhibit significant coverage in all samples with nst/Nst not being too
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Figure 8: Heatmaps of estimated cellular prevalences from PyClone (a) and pTRUEst (b) for
Simulation 2.
close to 0 or 1; and (iii) we used expert judgment to some more loci. The described filter
rules leave in the end S = 101 SNVs for the four intra-tumor samples. Figure 9 shows the
histograms of the total number of reads and the empirical read ratios, Nst and nst/Nst.
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Figure 9: Histograms of the Lung Cancer Dataset.
We used hyperparameters similar to those in the simulation studies. Figure 10 sum-
19
ll
l
l
l
l
l l
l l l l l l l
2 4 6 8 10 12 14
0.
0
0.
1
0.
2
0.
3
0.
4
C
P(
C|n
, N
)
N_st_hat − N_st
Fr
eq
ue
nc
y
−60 −40 −20 0 20 40 60
0
20
40
60
80
10
0
p_st_hat − (n_st/N_st)
Fr
eq
ue
nc
y
−0.15 −0.05 0.05 0.10 0.15
0
20
40
60
80
10
0
(a) p(C | n,N ) (b) Nˆst −Nst (c) pˆst − (nst/Nst)
Loci 
Subclones 
1 2
3322
3640
4888
8530
1735
684
8399
8982
9095
9297
9493
10138
845
4751
5291
8713
1049
139
1250
10076
3428
1511
1642
8632
245
319
2325
2641
4353
72
1820
3744
5455
9698
5829
6169
7178
2181
8065
4631
7227
475
7377
7966
6474
6057
6263
7056
149
6759
68
0 0.5 1 1.5 2 2.5 3
Value
0
Color Key
and Histogram
Co
un
t
Loci 
Subclones 
1 2
3322
3640
4888
8530
1735
684
8399
8982
9095
9297
9493
10138
845
4751
5291
8713
1049
139
1250
10076
3428
1511
1642
8632
245
319
2325
2641
4353
72
1820
3744
5455
9698
5829
6169
7178
2181
8065
4631
7227
475
7377
7966
6474
6057
6263
7056
149
6759
68
0 0.5 1 1.5 2 2.5 3
Value
0
Color Key
and Histogram
Co
un
t
Samples 
Subclones 
0 1 2
4
3
2
1
0.1 0.2 0.3 0.4 0.5
Value
0
4
Color Key
and Histogram
Co
un
t
(d) L? (e) Z? (f) w?
Figure 10: Posterior inference for the Lung Cancer Dataset.
marizes posterior inference under the proposed model. Panel (a) shows C? = 2, i.e., two
estimated subclones. Using posterior samples with C = C?, we computed Nˆst and pˆst and
compared them to the observed data. The differences are centered at 0, implying a good
fit to the data. Conditional on C? = 2, we found L?, Z? and w?. The loci in L? and Z?
are re-arranged in the same order for better illustration. From Figure 9(a) we notice that
many positions have large numbers of reads, over 200 reads. This is reflected in L? which
estimates three copies at many positions. The estimated weights w? in Figure 10(f) show
a great similarity across the four samples. This lack of heterogeneity across samples is not
surprising. The four samples were dissected from close-by spatial locations in the tumor.
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Figure 11: Heatmaps of estimated cellular prevalences from PyClone (a) and (nst/Nst) (b)
for the Lung cancer dataset.
Again, for comparison implemented PyClone (Roth et al., 2014) for the lung cancer data.
The posterior estimates of prevalence and the estimated clustering of the loci are shown in
Figure 11(a). The clustering identified five clusters of the loci. The mean prevalences within
a locus cluster are similar across samples, which is similar to w? in Figure 10(f). Panel (b)
of Figure 11 is a heatmap of fractions of reads bearing mutation for each locus and sample.
Again, PyClone provides a reasonable estimate of a loci clustering based on the empirical
fractions, but does not provide an inference on subclonal populations.
5 Conclusions
The proposed approach infers subclonal DNA copy numbers, subclonal variant allele counts
and cellular fractions in a biological sample. By jointly modeling CNV and SNV, we provide
the desired description of TH based on DNA variations in both, sequence and structure. Such
inference will significantly impact downstream treatment of individual tumors, ultimately
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allowing personalized prognosis. For example, tumor with large proportions of cells bearing
somatic mutations on tumor suppressor genes should be treated differently from those that
have no or a small proportion of such cells. In addition, metastatic or recurrent tumors may
possess very different compositions of cellular genomes and should be treated differently.
Inference on TH can be exploited for improved treatment strategies for relapsed cancer
patients, and can spark significant improvement in cancer treatment in practice.
A number of extensions are possible for the present model. For example, sometimes
additional sources of information on CNVs such as a SNP array may be available. We then
extend the proposed model to incorporate this information into the modeling of L. Another
meaningful extension is to cluster patients on the basis of the imputed TH, that is, we link a
random partition and a feature allocation model. This extension may help clinicians assign
different treatment strategies, and be the basis of adaptive clinical trial designs.
Inference for TH is a critical gap in the current literature. The ability to precisely break
down a tumor into a set of subclones with distinct genetics would provide the opportunity
for breakthroughs in cancer treatment by facilitating individualized treatment of the tumor
that exploits TH. It would open the door for cocktail type of combinational treatments, with
each treatment targeting a specific tumor subclone based on its genetic characteristics. We
believe that the proposed model may provide a integrated view on subclones to explain TH
that remains a mystery to scientists so far.
Acknowledgment
Yuan Ji and Peter Mu¨ller’s research is partially supported by NIH R01 CA132897.
22
References
Bedard, P. L., Hansen, A. R., Ratain, M. J., and Siu, L. L. (2013). Tumour heterogeneity
in the clinic. Nature 501, 7467, 355–364.
Biesecker, L. G. and Spinner, N. B. (2013). A genomic view of mosaicism and human disease.
Nature Reviews Genetics 14, 5, 307–320.
Broderick, T., Jordan, M. I., Pitman, J., et al. (2013). Cluster and feature modeling from
combinatorial stochastic processes. Statistical Science 28, 3, 289–312.
Brooks, S., Gelman, A., Jones, G., and Meng, X.-L. (2011). Handbook of Markov Chain
Monte Carlo. CRC Press.
Church, D. M., Schneider, V. A., Graves, T., Auger, K., Cunningham, F., Bouk, N., Chen,
H.-C., Agarwala, R., McLaren, W. M., Ritchie, G. R., et al. (2011). Modernizing reference
genome assemblies. PLoS biology 9, 7, e1001091.
De, S. (2011). Somatic mosaicism in healthy human tissues. Trends in Genetics 27, 6,
217–223.
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey,
J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012). Clonal evolution
in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481,
7382, 506–510.
Frank, S. A. and Nowak, M. A. (2003). Cell biology: Developmental predisposition to cancer.
Nature 422, 6931, 494–494.
Frank, S. A. and Nowak, M. A. (2004). Problems of somatic mutation and cancer. Bioessays
26, 3, 291–299.
23
Greaves, M. and Maley, C. C. (2012). Clonal evolution in cancer. Nature 481, 7381, 306–313.
Jiao, W., Vembu, S., Deshwar, A., Stein, L., and Morris, Q. (2014). Inferring clonal evolution
of tumors from single nucleotide somatic mutations. BMC Bioinformatics 15, 1, 35.
Kim, Y., James, L., and Weissbach, R. (2012). Bayesian analysis of multistate event history
data: beta-dirichlet process prior. Biometrika 99, 1, 127–140.
Klambauer, G., Schwarzbauer, K., Mayr, A., Clevert, D.-A., Mitterecker, A., Bodenhofer,
U., and Hochreiter, S. (2012). cn. mops: mixture of poissons for discovering copy number
variations in next-generation sequencing data with a low false discovery rate. Nucleic
Acids Research 40, 9, e69–e69.
Lee, J., Mu¨ller, P., Gulukota, K., and Ji, Y. (2014). A bayesian feature allocation model for
tumor heterogeneity.
Li, B. and Li, J. Z. (2014). A general framework for analyzing tumor subclonality using SNP
array and DNA sequencing data. Genome Biology in press.
Li, H. and Durbin, R. (2009a). Fast and accurate short read alignment with Burrows–Wheeler
transform. Bioinformatics 25, 14, 1754–1760.
Li, H. and Durbin, R. (2009b). Fast and accurate short read alignment with burrows–wheeler
transform. Bioinformatics 25, 14, 1754–1760.
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abeca-
sis, G., Durbin, R., et al. (2009). The sequence alignment/map format and samtools.
Bioinformatics 25, 16, 2078–2079.
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A.,
Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010a). The genome analy-
24
sis toolkit: a mapreduce framework for analyzing next-generation dna sequencing data.
Genome research 20, 9, 1297–1303.
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A.,
Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010b). The Genome Anal-
ysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing
data. Genome research 20, 9, 1297–1303.
Miller, C. A., White, B. S., Dees, N. D., Griffith, M., Welch, J. S., Griffith, O. L., Vij, R.,
Tomasson, M. H., Graubert, T. A., Walter, M. J., et al. (2014). Sciclone: Inferring clonal
architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS
computational biology 10, 8, e1003665.
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepan-
sky, A., Levy, D., Esposito, D., et al. (2011). Tumour evolution inferred by single-cell
sequencing. Nature 472, 7341, 90–94.
Oesper, L., Mahmoody, A., and Raphael, B. J. (2013). Theta: inferring intra-tumor hetero-
geneity from high-throughput dna sequencing data. Genome Biol 14, 7, R80.
Roth, A., Khattra, J., Yap, D., Wan, A., Laks, E., Biele, J., Ha, G., Aparicio, S., Bouchard-
Coˆte´, A., and Shah, S. P. (2014). Pyclone: statistical inference of clonal population
structure in cancer. Nature methods .
Russnes, H. G., Navin, N., Hicks, J., and Borresen-Dale, A.-L. (2011). Insight into the
heterogeneity of breast cancer through next-generation sequencing. The Journal of Clinical
Investigation 121, 10, 3810–3818.
Sengupta, S. (2013). Two models involving bayesian nonparametric techniques (ph.d thesis).
25
Sengupta, S., Guluokta, K., Lee, J., Mu¨ller, P., and Ji, Y. (2015). Bayclone: Bayesian
nonparametric inference of tumor subclones using ngs data. In Proceedings of The Pacific
Symposium on Biocomputing (PSB) 2015, in press.
Strino, F., Parisi, F., Micsinai, M., and Kluger, Y. (2013). Trap: a tree approach for
fingerprinting subclonal tumor composition. Nucleic Acids Research 41, 17, e165.
Zare, H., Wang, J., Hu, A., Weber, K., Smith, J., Nickerson, D., Song, C., Witten, D., Blau,
C. A., and Noble, W. S. (2014). Inferring clonal composition from multiple sections of a
breast cancer. PLoS computational biology 10, 7, e1003703.
26
